中文名 | 靛玉红-3' -单肟 |
英文名 | INDIRUBIN-3'-MONOXIME |
别名 | 靛玉红-3 靛玉红-3'-肟 靛玉红-3' -单肟 3-(肟基)-[2,3'-双吲哚啉亚基]-2'-酮 3-(羟基亚氨基)-[2,3'-双吲哚啉亚基]-2'-酮 GSK-3Β抑制剂(INDIRUBIN-3-MONOXIME) |
英文别名 | Indirubin-3 INDIRUBIN-3'-OXIME Indirubine-3'-oxime INDIRUBIN-3'-MONOXIME INDIRUBIN-3'-MONOOXIME 3-(hydroxyamino)-1H,2'H-2,3'-biindol-2'-one 3-(Hydroxyimino)-[2,3'-biindolinylidene]-2'-one 3-[1,3-DIHYDRO-3-(HYDROXYIMINO)-2H-INDOL-2-YLIDENE]-1,3-DIHYDRO-2H-INDOL-2-ONE |
CAS | 160807-49-8 |
化学式 | C16H11N3O2 |
分子量 | 277.28 |
InChI | InChI=1/C16H11N3O2/c20-16-13(9-5-1-3-7-11(9)18-16)15-14(19-21)10-6-2-4-8-12(10)17-15/h1-8,17,21H,(H,18,20)/b15-13-,19-14+ |
密度 | 1.50 |
熔点 | 247-249°C |
沸点 | 532.2±50.0 °C(Predicted) |
水溶性 | DMSO: >10 mg/mL |
溶解度 | DMSO: >10 mg/mL |
酸度系数 | 8.66±0.20(Predicted) |
存储条件 | room temp |
稳定性 | 光敏 |
外观 | 固体 |
颜色 | Dark red or brown |
体外研究 | Indirubin-3'-monoxime inhibits GSK-3β by competing with ATP, with K i of 0.85 μM, and K m of 110 μM. Indirubin-3'-monoxime also inhibits tau phosphorylation by GSK-3β, with an IC 50 value of around 100 nM. Indirubin-3'-monoxime completely inhibits the phosphorylation of the AT100 epitope. Indirubin-3'-monoxime inhibits vascular smooth muscle cell (VSMC) proliferation with IC 50 of ∼2 µM. Indirubin-3'-monoxime blunts migration of VSMC stimulated with the PDGF. Indirubin-3'-monoxime interferes with the migratory response in VSMC, and also suppresses the production of pro-migratory LT in monocytes. Moreover, Indirubin-3'-monoxime inhibits 5-lipoxygenase (5-LO) product synthesis in monocytes and neutrophils, with the same potency (IC 50 =5.0±1.1 and 3.7±1.2 µM, respectively). Indirubin-3'-monoxime is an inhibitor of 5-LO, with IC 50 of 7.8-10 µM in cell-free assay. |
体内研究 | Indirubin-3'-monoxime (0.1, 0.2 and 0.4 mg/kg, i.p) dose dependently reverses the cognitive impairment and combats the elevated oxidative stress markers in HFD fed mice. Indirubin-3'-monoxime also dose dependently lowers the serum glucose, TGs, TC and insulin levels, and improves the β-cell functioning in HFD fed mice. Moreover, Indirubin-3'-monoxime treatment significantly decreases HOMA-IR levels compared to HFD group. Indirubin-3'-monoxime (0.4 mg/kg) significantly attenuates the increased EL in the HFD group. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.607 ml | 18.033 ml | 36.065 ml |
5 mM | 0.721 ml | 3.607 ml | 7.213 ml |
10 mM | 0.361 ml | 1.803 ml | 3.607 ml |
5 mM | 0.072 ml | 0.361 ml | 0.721 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!